Incyte director awarded 265 restricted shares
INCYTE CORP director Paul J. Clancy received 265 shares of common stock as a fully vested restricted share award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
INCYTE CORP director Paul J. Clancy received 265 shares of common stock as a fully vested restricted share award. The grant was made under Incyte's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees, pursuant to an election intended to comply with Rule 10b5-1. Following this compensation-related acquisition, he holds 23,741 shares directly, including 2,518 shares of common stock issuable from previously reported restricted stock units that have not yet vested.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 265 | $94.12 | $25K |
Footnotes (2)
- F1. Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested.
- F2. This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Key Figures
Key Terms
Rule 10b5-1 regulatory
restricted stock units financial
director retainer fees financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Incyte (INCY) director Paul J. Clancy report on this Form 4?
What are the restricted stock units mentioned in Paul J. Clancy’s Incyte (INCY) filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.